| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5931871 | The American Journal of the Medical Sciences | 2015 | 8 Pages |
Abstract
Among patients with ADHF, intravenous infusion of levosimendan and nesiritide was superior to placebo and single-drug therapies in terms of improvements in clinical conditions during the early stages of therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Zhi MS, Mu MS, Li-Yuan MS, Yun-Qiang PhD, Hai-Qing MS, Yu MS,